CRISPR/Cas technologies in pancreatic cancer research and therapeutics: recent advances and future outlook

Abstract Pancreatic cancer is marked by a poor prognosis and an exceptionally high mortality rate, with its aggressive nature contributing to its classification as a highly malignant disease. For effective therapeutic strategies, the development of sophisticated and regulated DNA manipulation method...

Full description

Saved in:
Bibliographic Details
Main Authors: Hanieh Noormohamadi, Hamed Soleimani Samarkhazan, Maryam kargar, Faezeh Maroufi, Nazli Servatian, Fatemeh Davami
Format: Article
Language:English
Published: Springer 2025-08-01
Series:Discover Oncology
Subjects:
Online Access:https://doi.org/10.1007/s12672-025-03383-5
Tags: Add Tag
No Tags, Be the first to tag this record!